Through the Looking Glass: Updated Insights on Ovarian Cancer Diagnostics
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Through the Looking Glass: Updated Insights on Ovarian Cancer Diagnostics
Authors
Keywords
-
Journal
Diagnostics
Volume 13, Issue 4, Pages 713
Publisher
MDPI AG
Online
2023-02-14
DOI
10.3390/diagnostics13040713
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Plasma circN4BP2L2 is a promising novel diagnostic biomarker for epithelial ovarian cancer
- (2022) Li Ning et al. BMC CANCER
- Identifying Mitotic Kinesins as Potential Prognostic Biomarkers in Ovarian Cancer Using Bioinformatic Analyses
- (2022) Hailun Liu et al. Diagnostics
- Long non-coding RNA SNHG10 upregulates BIN1 to suppress the tumorigenesis and epithelial–mesenchymal transition of epithelial ovarian cancer via sponging miR-200a-3p
- (2022) Wei Lv et al. Cell Death Discovery
- PTH2R is related to cell proliferation and migration in ovarian cancer: a multi-omics analysis of bioinformatics and experiments
- (2022) Wang Xiaowei et al. Cancer Cell International
- Exosomal MicroRNA as Biomarkers for Diagnosing or Monitoring the Progression of Ovarian Clear Cell Carcinoma: A Pilot Study
- (2022) Kayo Horie et al. MOLECULES
- Genome-Wide Identification and Validation of Gene Expression Biomarkers in the Diagnosis of Ovarian Serous Cystadenocarcinoma
- (2022) Francesca Zalfa et al. Cancers
- Correlation of BRCA and HRD status with clinical and survival outcomes in patients with advanced-stage ovarian cancer in the age of PARPi maintenance therapy (187)
- (2022) Travis Sims et al. GYNECOLOGIC ONCOLOGY
- Exosome-based liquid biopsies in cancer: opportunities and challenges
- (2021) W. Yu et al. ANNALS OF ONCOLOGY
- Clinical characteristics and prognosis of ovarian clear cell carcinoma: a 10-year retrospective study
- (2021) Chenchen Zhu et al. BMC CANCER
- Potential Use of Exosomes as Diagnostic Biomarkers and in Targeted Drug Delivery: Progress in Clinical and Preclinical Applications
- (2021) Md Nurul Huda et al. ACS Biomaterials-Science & Engineering
- Glycomic-Based Biomarkers for Ovarian Cancer: Advances and Challenges
- (2021) Francis Mugeni Wanyama et al. Diagnostics
- Exosomal miRNA-205 promotes breast cancer chemoresistance and tumorigenesis through E2F1
- (2021) Yan Zhao et al. Aging-US
- New biomarkers in peripheral blood of patients with ovarian cancer: high expression levels of miR-16-5p, miR-17-5p, and miR-638
- (2021) Mukaddes Avsar Saral et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- The role of homologous recombination deficiency testing in ovarian cancer and its clinical implications: do we need it?
- (2021) N.Y.L. Ngoi et al. ESMO Open
- Clinical factors and biomarker profiles associated with patient outcome in endometrioid ovarian carcinoma - Emphasis on tumor grade
- (2021) Piret Soovares et al. GYNECOLOGIC ONCOLOGY
- Hormone receptor expression and outcomes in low-grade serous ovarian carcinoma
- (2020) Marta Llaurado Fernandez et al. GYNECOLOGIC ONCOLOGY
- Therapeutic options for mucinous ovarian carcinoma
- (2020) Kylie L. Gorringe et al. GYNECOLOGIC ONCOLOGY
- Circulating Tumor Cell Detection In Epithelial Ovarian Cancer Using Dual-Component Antibodies Targeting EpCAM And FRα
- (2020) Na Li et al. Cancer Management and Research
- Comparison of HE 4, CA 125, ROMA score and ultrasound score in the differential diagnosis of ovarian masses
- (2020) Koray Aslan et al. Journal of Gynecology Obstetrics and Human Reproduction
- Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples
- (2020) Marco Russano et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The Origin of Ovarian Cancer Species and Precancerous Landscape
- (2020) Ie-Ming Shih et al. AMERICAN JOURNAL OF PATHOLOGY
- ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer
- (2020) R.E. Miller et al. ANNALS OF ONCOLOGY
- Serum CA19 ‐9, CA ‐125 and CEA as tumor markers for mucinous ovarian tumors
- (2020) Arb‐aroon Lertkhachonsuk et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- Genomic analysis of low‐grade serous ovarian carcinoma to identify key drivers and therapeutic vulnerabilities
- (2020) Dane Cheasley et al. JOURNAL OF PATHOLOGY
- PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance
- (2020) Maddison Rose et al. Frontiers in Cell and Developmental Biology
- Cu isotope ratios are meaningful in ovarian cancer diagnosis
- (2020) B. Toubhans et al. JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY
- Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments
- (2019) Ming-Jun Zheng et al. JOURNAL OF CELLULAR PHYSIOLOGY
- IGF1R predicts better survival in high-grade serous epithelial ovarian cancer patients and correlates with hCtr1 levels
- (2019) Abhilash Deo et al. Biomarkers in Medicine
- Serum circSETDB1 is a promising biomarker for predicting response to platinum-taxane-combined chemotherapy and relapse in high-grade serous ovarian cancer
- (2019) Wei Wang et al. OncoTargets and Therapy
- Epigenetic Biomarkers in the Management of Ovarian Cancer: Current Prospectives
- (2019) Alka Singh et al. Frontiers in Cell and Developmental Biology
- Utility Of Plasma circBNC2 As A Diagnostic Biomarker In Epithelial Ovarian Cancer
- (2019) Yingchao Hu et al. OncoTargets and Therapy
- Increased expression of TET3 predicts unfavorable prognosis in patients with ovarian cancer-a bioinformatics integrative analysis
- (2019) Tiefeng Cao et al. Journal of Ovarian Research
- Identification of Potential Biomarkers in Association With Progression and Prognosis in Epithelial Ovarian Cancer by Integrated Bioinformatics Analysis
- (2019) Jinhui Liu et al. Frontiers in Genetics
- Liquid biopsy in ovarian cancer: recent advances on circulating tumor cells and circulating tumor DNA
- (2018) Lydia Giannopoulou et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Diagnostic and Prognostic Biomarkers in ovarian cancer and the potential roles of cancer stem cells – An updated review
- (2018) Thingreila Muinao et al. EXPERIMENTAL CELL RESEARCH
- Combining serum microRNA and CA-125 as prognostic indicators of preoperative surgical outcome in women with high-grade serous ovarian cancer
- (2018) Jaynish S. Shah et al. GYNECOLOGIC ONCOLOGY
- ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma
- (2018) Emi Sato et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Biomarker Assessment of HR Deficiency, TumorBRCA1/2Mutations, andCCNE1Copy Number in Ovarian Cancer: Associations with Clinical Outcome Following Platinum Monotherapy
- (2018) Euan A. Stronach et al. MOLECULAR CANCER RESEARCH
- ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors
- (2018) Katrien Berns et al. ONCOGENE
- WT1, p53 and p16 expression in the diagnosis of low- and high-grade serous ovarian carcinomas and their relation to prognosis
- (2018) Luis Felipe Sallum et al. Oncotarget
- Mechanisms for stalled replication fork stabilization: new targets for synthetic lethality strategies in cancer treatments
- (2018) Hongwei Liao et al. EMBO REPORTS
- Exosomal microRNAs as tumor markers in epithelial ovarian cancer
- (2018) Chi Pan et al. Molecular Oncology
- Current advancement on diagnosis of ovarian cancer using biosensing of CA 125 biomarker: Analytical approaches
- (2018) Nasrin Razmi et al. TRAC-TRENDS IN ANALYTICAL CHEMISTRY
- Prognostic significance of Ki-67 levels and hormone receptor expression in low-grade serous ovarian carcinoma: an investigation of the tumor bank ovarian cancer network
- (2018) Jalid Sehouli et al. HUMAN PATHOLOGY
- Mechanisms of DNA damage, repair, and mutagenesis
- (2017) Nimrat Chatterjee et al. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
- The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review
- (2017) Giuseppe Scaletta et al. Expert Review of Anticancer Therapy
- The role of biomarkers in the management of epithelial ovarian cancer
- (2017) Wei-Lei Yang et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Ovarian cancer early detection by circulating CA125 in the context of anti-CA125 autoantibody levels: Results from the EPIC cohort
- (2017) Renée T. Fortner et al. INTERNATIONAL JOURNAL OF CANCER
- The Role of HE4, a Novel Biomarker, in Predicting Optimal Cytoreduction After Neoadjuvant Chemotherapy in Advanced Ovarian Cancer
- (2017) Francesco Plotti et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Ovarian cancer recurrence and early detection: may HE4 play a key role in this open challenge? A systematic review of literature
- (2017) Stella Capriglione et al. MEDICAL ONCOLOGY
- Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
- (2017) Xianliang Cheng et al. Journal of Ovarian Research
- EMT-like circulating tumor cells in ovarian cancer patients are enriched by platinum-based chemotherapy
- (2017) Issam Chebouti et al. Oncotarget
- The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer
- (2017) Martin Widschwendter et al. Genome Medicine
- A multiplex platform for the identification of ovarian cancer biomarkers
- (2017) Kristin L. M. Boylan et al. Clinical Proteomics
- Validation of a second-generation multivariate index assay for malignancy risk of adnexal masses
- (2016) Robert L. Coleman et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- A Systematic Review of Symptoms for the Diagnosis of Ovarian Cancer
- (2016) Mark H. Ebell et al. AMERICAN JOURNAL OF PREVENTIVE MEDICINE
- Homologous recombination deficiency and ovarian cancer
- (2016) Jonathan A. Ledermann et al. EUROPEAN JOURNAL OF CANCER
- Wilms tumor protein 1 (WT1) — Not only a diagnostic but also a prognostic marker in high-grade serous ovarian carcinoma
- (2016) Eliane Tabea Taube et al. GYNECOLOGIC ONCOLOGY
- Ovarian cancer
- (2016) Ursula A. Matulonis et al. Nature Reviews Disease Primers
- Diagnostic values of osteopontin combined with CA125 for ovarian cancer: a meta-analysis
- (2015) Zhu Lan et al. Familial Cancer
- Modulatory role ofmiR-205in angiogenesis and progression of thyroid cancer
- (2015) Ali Salajegheh et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Genomic Classification of Serous Ovarian Cancer with Adjacent Borderline Differentiates RAS Pathway and TP53-Mutant Tumors and Identifies NRAS as an Oncogenic Driver
- (2014) C. Emmanuel et al. CLINICAL CANCER RESEARCH
- Checkpoint kinase 2 (Chk2) supports sensitivity to platinum-based treatment in high grade serous ovarian cancer
- (2014) N.G. Alkema et al. GYNECOLOGIC ONCOLOGY
- Napsin A is a specific marker for ovarian clear cell adenocarcinoma
- (2014) Yoriko Yamashita et al. MODERN PATHOLOGY
- Review of Poly (ADP-ribose) Polymerase (PARP) Mechanisms of Action and Rationale for Targeting in Cancer and Other Diseases
- (2013) Julio Morales et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- Ovarian carcinoma histotype determination is highly reproducible, and is improved through the use of immunohistochemistry
- (2013) Martin Köbel et al. HISTOPATHOLOGY
- HNF-1β in Ovarian Carcinomas With Serous and Clear Cell Change
- (2013) Deborah DeLair et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations and ZNF217 amplification in ovarian clear cell carcinoma
- (2013) Hsien-Neng Huang et al. MODERN PATHOLOGY
- Hereditary breast and ovarian cancer susceptibility genes (Review)
- (2013) HIROSHI KOBAYASHI et al. ONCOLOGY REPORTS
- HER2 Amplification and Clinicopathological Characteristics in a Large Asian Cohort of Rare Mucinous Ovarian Cancer
- (2013) Wen-Yee Chay et al. PLoS One
- Cancer bioinformatics: A new approach to systems clinical medicine
- (2012) Duojiao Wu et al. BMC BIOINFORMATICS
- The Changing View of High-Grade Serous Ovarian Cancer
- (2012) E. M. J. J. Berns et al. CANCER RESEARCH
- Diagnostic value of HE4 for ovarian cancer: a meta-analysis
- (2012) Shuang Yu et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Homologous recombination and its regulation
- (2012) L. Krejci et al. NUCLEIC ACIDS RESEARCH
- Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm
- (2011) Robert J. Kurman et al. HUMAN PATHOLOGY
- miRNA-205 Suppresses Melanoma Cell Proliferation and Induces Senescence via Regulation of E2F1 Protein
- (2011) Altaf A. Dar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer
- (2011) Fiona Furlong et al. JOURNAL OF PATHOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Evaluation of the Diagnostic Accuracy of the Risk of Ovarian Malignancy Algorithm in Women With a Pelvic Mass
- (2011) Richard G. Moore et al. OBSTETRICS AND GYNECOLOGY
- Statistical Evaluation of a Biomarker
- (2010) Patrick Ray et al. ANESTHESIOLOGY
- HOXA10 is Overexpressed in Human Ovarian Clear Cell Adenocarcinoma and Correlates With Poor Survival
- (2010) Bin Li et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- HE4: a new potential early biomarker for the recurrence of ovarian cancer
- (2010) Emanuela Anastasi et al. TUMOR BIOLOGY
- Glypican-3 expression in clear cell adenocarcinoma of the ovary
- (2009) Daichi Maeda et al. MODERN PATHOLOGY
- Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma
- (2008) Hiroaki Itamochi et al. CANCER SCIENCE
- Homologous recombination in DNA repair and DNA damage tolerance
- (2008) Xuan Li et al. CELL RESEARCH
- MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer
- (2008) Douglas D. Taylor et al. GYNECOLOGIC ONCOLOGY
- A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
- (2008) Richard G. Moore et al. GYNECOLOGIC ONCOLOGY
- The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
- (2008) Philip A. Gregory et al. NATURE CELL BIOLOGY
- WT1 expression in endometrioid ovarian carcinoma with and without associated endometriosis
- (2008) C.J.R. Stewart et al. PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now